Author response

Comment

Robert J Fox. Neurology. 2014.

. 2014 Nov 25;83(22):2100.

No abstract available

Comment on

MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.
Fox RJ, Cree BA, De Sèze J, Gold R, Hartung HP, Jeffery D, Kappos L, Kaufman M, Montalbán X, Weinstock-Guttman B, Anderson B, Natarajan A, Ticho B, Duda P; RESTORE. Fox RJ, et al. Neurology. 2014 Apr 29;82(17):1491-8. doi: 10.1212/WNL.0000000000000355. Epub 2014 Mar 28. Neurology. 2014. PMID: 24682966 Free PMC article. Clinical Trial.
MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study.
Svenningsson A, Sundstrom P, Salzer J, Vagberg M. Svenningsson A, et al. Neurology. 2014 Nov 25;83(22):2099-100. doi: 10.1212/01.wnl.0000457455.74798.9a. Neurology. 2014. PMID: 25422402 No abstract available.